Polyphenol-Rich Diets Associated with Slower Biological Aging: Insights from a Clinical Trial

A study, published in September 2023, explored the impact of different diets on biological aging, which is a measure of how fast your body is aging based on DNA methylation.

They used various DNA methylation-based aging clocks to assess this in 256 participants with abdominal obesity or dyslipidemia over an 18-month period.

The participants were divided into three diet groups:

one following healthy dietary guidelines,
one on a Mediterranean (MED) diet, and
one on a polyphenol-rich, low-red/processed meat Green-MED diet.

The Green-MED diet included walnuts, green tea, and Mankai, a green plant, with higher polyphenol content.

The researchers found that participants who adhered more closely to the Green-MED diet had a slower rate of biological aging, as indicated by specific methylation aging clocks known as Li and Hannum methylation age.

This slowing of biological aging was associated with increased intake of Mankai and green tea, and it corresponded with higher levels of polyphenols in urine.

Overall, participants following either the MED-style or Green-MED diets showed a nearly 9-month reduction in their biological age compared to what would be expected based on their chronological age.

This suggests that diets rich in polyphenols, such as those found in green tea and Mankai, may have a positive impact on biological aging.

This study is one of the first clinical trials to suggest a potential link between polyphenol intake, urine polyphenol levels, and the rate at which the body ages.

Source: Yaskolka Meir, A., Keller, M., Hoffmann, A. et al. The effect of polyphenols on DNA methylation-assessed biological age attenuation: the DIRECT PLUS randomized controlled trial. BMC Med 21, 364 (2023). https://doi.org/10.1186/s12916-023-03067-3

Comments

Exploring the Link Between Circadian Rhythms, Longevity, and Wearable Data: Insights and Future Directions

A recent study in NHANES 2011–2014 explores the potential connection between disruptions in circadian rhythms, measured using wearable devices, and their impact on health outcomes and longevity. The study analyzes data from 7,297 U.S. adults collected through wearable accelerometers as a novel digital biomarker for longevity. Five distinct clusters were identified based on activity profiles: "High activity," "Low activity," "Mild circadian rhythm (CR) disruption," "Severe CR disruption," and "Very low activity." The findings reveal that young adults with extreme circadian rhythm disturbance exhibit higher white blood cell counts and accelerated biological aging. Older adults with circadian disruption are associated with increased systemic inflammation indexes, advanced biological aging, and higher all-cause mortality risk. The research underscores the importance of circadian alignment for longevity at all ages and suggests that wearable

The safety of aspartame is under review by WHO after conflicting findings.

Aspartame, a sweetener with health effects Since 1981, the WHO expert committee on additives has confirmed the safety of aspartame consumption within acceptable daily limits. The international organization has established that the acceptable daily intake (ADI) of aspartame is 40 milligrams per kilogram of body weight. This means that a person can consume up to 40 mg of aspartame per kilogram of their body weight per day without risking their health. For example, if someone weighs 60 kilos, the allowable amount of aspartame would be 2,400 milligrams (40 mg/kg x 60 kg). In recent years, several studies have been carried out on the effects of aspartame on health. The Food and Drug Administration (FDA) has reviewed the scientific evidence related to the safety of this sweetener five times since its approval in 1981, and has concluded that it remains safe for use. However, it is being studied again. It has an especially important use in low-calorie beverages consumed by children and pregnan

Light Therapy holds promise as a treatment for Alzheimer's Disease

A new article, conducted by Lili Zang and colleagues from Weifang Medical University School of Nursing in Shandong Province, China, discusses a meta-analysis of 15 high-quality trials that investigated the impact of light therapy on individuals with Alzheimer’s disease (AD). The meta-analysis included 598 patients with mild to moderate Alzheimer’s disease, and it covered 15 randomized controlled trials conducted in seven different countries. Those trials were published between 2005 and 2022. Sleep Improvement Light therapy led to significant improvements in several sleep measures. It notably enhanced sleep efficiency, increased interdaily stability, and reduced intradaily variability, all of which are indicators of better sleep quality. Light therapy was associated with a reduction in agitation, depression, and caregiver burden among individuals with Alzheimer’s disease. A significant advantage over usual care was shown in reducing the severity of psychobehavioral symptoms, as assessed

Wellness-uptodate

Search This Blog